Determining the role of genetic risk scores in symptomatic cancer detection

Affiliations

¹ DISCOVERY Group, University of Exeter Medical School, University of Exeter, Exeter, UK.
² Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
³ Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, US.
⁴ University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre; Department of General Practice, University of Melbourne, Victoria, Australia.
⁵ GP and National Institute for Health and Care Research Academic Clinical Lecturer, Centre for Primary Care and Health Services Research, University of Manchester, Manchester.

Editorial

Sarah Er Bailey et al. Br J Gen Pract. 2023.

. 2023 Feb 23;73(728):106-107.

doi: 10.3399/bjgp23X732069. Print 2023 Mar.

¹ DISCOVERY Group, University of Exeter Medical School, University of Exeter, Exeter, UK.
² Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
³ Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, US.
⁴ University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre; Department of General Practice, University of Melbourne, Victoria, Australia.
⁵ GP and National Institute for Health and Care Research Academic Clinical Lecturer, Centre for Primary Care and Health Services Research, University of Manchester, Manchester.

No abstract available

References

1. NHS England The NHS Long Term Plan. 2019 https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term... (accessed 8 Feb 2023).
1. Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract. 2010. DOI: . - DOI - PMC - PubMed
1. Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer — determining the patient journey using multiple routine data sets. Br J Cancer. 2012;107(8):1220–1226. - PMC - PubMed
1. National Institute for Health and Care Excellence . Suspected cancer: recognition and referral NG12. London: NICE; 2021. https://www.nice.org.uk/guidance/ng12 (accessed 7 Feb 2023). - PubMed
1. Conran C, Na R, Chen H, et al. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer. Asian J Androl. 2016;18(4):520–524. - PMC - PubMed